• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔菌群失调与帕金森病的炎症反应

Oral Dysbiosis and Inflammation in Parkinson's Disease.

机构信息

Faculty of Medicine, University of Geneva, CMU, Geneva, Switzerland.

Division of Neurology, Geneva University Hospitals, Geneva, Switzerland.

出版信息

J Parkinsons Dis. 2021;11(2):619-631. doi: 10.3233/JPD-202459.

DOI:10.3233/JPD-202459
PMID:33646178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8150470/
Abstract

BACKGROUND

Oral microbiota has largely escaped attention in Parkinson's disease (PD), despite its pivotal role in maintaining oral and systemic health.

OBJECTIVE

The aim of our study was to examine the composition of the oral microbiota and the degree of oral inflammation in PD.

METHODS

Twenty PD patients were compared to 20 healthy controls. Neurological, periodontal and dental examinations were performed as well as dental scaling and gingival crevicular fluid sampling for cytokines measurement (interleukine (IL)-1β, IL-6, IL-1 receptor antagonist (RA), interferon-γ and tumor necrosis factor (TNF)-α). Two months later, oral microbiota was sampled from saliva and subgingival dental plaque. A 16S rRNA gene amplicon sequencing was used to assess bacterial communities.

RESULTS

PD patients were in the early and mid-stage phases of their disease (Hoehn & Yahr 2-2.5). Dental and periodontal parameters did not differ between groups. The levels of IL-1β and IL-1RA were significantly increased in patients compared to controls with a trend for an increased level of TNF-α in patients. Both saliva and subgingival dental plaque microbiota differed between patients and controls. Streptococcus mutans, Kingella oralis, Actinomyces AFQC_s, Veillonella AFUJ_s, Scardovia, Lactobacillaceae, Negativicutes and Firmicutes were more abundant in patients, whereas Treponema KE332528_s, Lachnospiraceae AM420052_s, and phylum SR1 were less abundant.

CONCLUSION

Our findings show that the oral microbiome is altered in early and mid-stage PD. Although PD patients had good dental and periodontal status, local inflammation was already present in the oral cavity. The relationship between oral dysbiosis, inflammation and the pathogenesis of PD requires further study.

摘要

背景

尽管口腔微生物群在维持口腔和全身健康方面起着关键作用,但在帕金森病 (PD) 中,它在很大程度上被忽视了。

目的

我们的研究旨在检查 PD 患者口腔微生物群的组成和口腔炎症程度。

方法

将 20 名 PD 患者与 20 名健康对照进行比较。进行了神经学、牙周和牙科检查,以及牙齿清洁和牙龈沟液取样以测量细胞因子(白细胞介素 (IL)-1β、IL-6、IL-1 受体拮抗剂 (RA)、干扰素-γ 和肿瘤坏死因子 (TNF)-α)。两个月后,从唾液和龈下牙菌斑中采集口腔微生物群样本。使用 16S rRNA 基因扩增子测序来评估细菌群落。

结果

PD 患者处于疾病的早期和中期阶段(Hoehn & Yahr 2-2.5)。两组之间的牙齿和牙周参数没有差异。与对照组相比,患者的 IL-1β 和 IL-1RA 水平显着升高,患者的 TNF-α 水平呈升高趋势。患者和对照组的唾液和龈下牙菌斑微生物群存在差异。变形链球菌、口腔 Kingella 菌、AFQC_s 放线菌、AFUJ_s 韦荣球菌、Scardovia、乳杆菌科、阴性杆菌和Firmicutes 在患者中更为丰富,而 Treponema KE332528_s、Lachnospiraceae AM420052_s 和 SR1 门在患者中较少。

结论

我们的研究结果表明,口腔微生物组在早期和中期 PD 中发生改变。尽管 PD 患者的牙齿和牙周状况良好,但口腔内已经存在局部炎症。口腔微生物失调、炎症与 PD 发病机制之间的关系需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/ef52cd710fa9/jpd-11-jpd202459-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/c591f2bac3ed/jpd-11-jpd202459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/a4a675ea3c7f/jpd-11-jpd202459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/ef52cd710fa9/jpd-11-jpd202459-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/c591f2bac3ed/jpd-11-jpd202459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/a4a675ea3c7f/jpd-11-jpd202459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5dc/8150470/ef52cd710fa9/jpd-11-jpd202459-g003.jpg

相似文献

1
Oral Dysbiosis and Inflammation in Parkinson's Disease.口腔菌群失调与帕金森病的炎症反应
J Parkinsons Dis. 2021;11(2):619-631. doi: 10.3233/JPD-202459.
2
Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.唾液微生物组失调和细胞因子通过炎症影响口腔鳞状细胞癌。
Arch Microbiol. 2021 Jan;203(1):137-152. doi: 10.1007/s00203-020-02011-w. Epub 2020 Aug 11.
3
Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.帕金森病患者/健康配偶的肠道微生物群改变及其与临床特征的关系。
Parkinsonism Relat Disord. 2020 Dec;81:84-88. doi: 10.1016/j.parkreldis.2020.10.034. Epub 2020 Oct 20.
4
Oral microbial dysbiosis in patients with Kostmann syndrome.Kostmann 综合征患者的口腔微生物失调。
J Med Microbiol. 2019 Apr;68(4):609-615. doi: 10.1099/jmm.0.000964. Epub 2019 Mar 15.
5
Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.口腔微生物失调及其与自身免疫性肝病唾液免疫生物学标志物的关系。
PLoS One. 2018 Jul 3;13(7):e0198757. doi: 10.1371/journal.pone.0198757. eCollection 2018.
6
Oral, Nasal, and Gut Microbiota in Parkinson's Disease.口腔、鼻腔和肠道微生物群与帕金森病。
Neuroscience. 2022 Jan 1;480:65-78. doi: 10.1016/j.neuroscience.2021.10.011. Epub 2021 Oct 22.
7
Subgingival microbiome of deep and shallow periodontal sites in patients with rheumatoid arthritis: a pilot study.类风湿关节炎患者深牙周袋和浅牙周袋的龈下微生物组:一项初步研究。
BMC Oral Health. 2021 May 8;21(1):248. doi: 10.1186/s12903-021-01597-x.
8
Oral and intestinal dysbiosis in Parkinson's disease.帕金森病的口腔和肠道菌群失调。
Rev Neurol (Paris). 2023 Nov;179(9):937-946. doi: 10.1016/j.neurol.2022.12.010. Epub 2023 Mar 16.
9
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.粪便微生物群移植对 1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病小鼠的神经保护作用:肠道微生物群、神经胶质反应和 TLR4/TNF-α 信号通路。
Brain Behav Immun. 2018 May;70:48-60. doi: 10.1016/j.bbi.2018.02.005. Epub 2018 Feb 20.
10
Dysbiosis of gut microbiota in a selected population of Parkinson's patients.特定帕金森病患者人群的肠道微生物失调。
Parkinsonism Relat Disord. 2019 Aug;65:124-130. doi: 10.1016/j.parkreldis.2019.06.003. Epub 2019 Jun 3.

引用本文的文献

1
Exploring the Role of Oral Microbiota in the Pathophysiology and Treatment of Bruxism.探索口腔微生物群在磨牙症病理生理学及治疗中的作用。
FASEB J. 2025 Sep 15;39(17):e71017. doi: 10.1096/fj.202502015R.
2
Evaluating dental health in patients with different severity of Parkinson's disease: a cross-sectional study.评估不同严重程度帕金森病患者的口腔健康状况:一项横断面研究。
BMC Oral Health. 2025 Jul 4;25(1):1095. doi: 10.1186/s12903-025-06448-7.
3
Human oral microbiome and its influence on mental health and brain disorders.人类口腔微生物群及其对心理健康和脑部疾病的影响。

本文引用的文献

1
Innate and adaptive immune responses in Parkinson's disease.帕金森病中的先天免疫和适应性免疫反应。
Prog Brain Res. 2020;252:169-216. doi: 10.1016/bs.pbr.2019.10.006. Epub 2019 Dec 5.
2
Implications of the Gut Microbiome in Parkinson's Disease.肠道微生物组在帕金森病中的意义。
Mov Disord. 2020 Jun;35(6):921-933. doi: 10.1002/mds.28004. Epub 2020 Feb 24.
3
NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.NF-κB 介导的帕金森病神经炎症及多酚的潜在治疗作用。
AIMS Microbiol. 2025 Apr 14;11(2):242-294. doi: 10.3934/microbiol.2025013. eCollection 2025.
4
Review of the mechanism of infection induced cerebral small vessel disease.感染性脑小血管病发病机制综述。
Front Immunol. 2025 May 26;16:1594891. doi: 10.3389/fimmu.2025.1594891. eCollection 2025.
5
An update on the involvement of inflammatory mediators in Parkinson's disease pathogenesis.炎症介质在帕金森病发病机制中的作用新进展。
Arch Toxicol. 2025 Jun 3. doi: 10.1007/s00204-025-04088-y.
6
Association between oral dysbiosis and Parkinson's disease: a systematic review.口腔微生物失调与帕金森病之间的关联:一项系统评价
Front Cell Infect Microbiol. 2025 May 13;15:1564362. doi: 10.3389/fcimb.2025.1564362. eCollection 2025.
7
Altered oral health and microbiota in drug-free patients with schizophrenia.精神分裂症未服药患者的口腔健康和微生物群改变
BMC Psychiatry. 2025 Mar 25;25(1):274. doi: 10.1186/s12888-025-06633-6.
8
Periodontitis: Grade Modifiers Revisited.牙周炎:再探分级修饰词。
Oral Dis. 2025 Jun;31(6):1637-1646. doi: 10.1111/odi.15297. Epub 2025 Feb 27.
9
Potential Biomarkers and Treatment of Neuroinflammation in Parkinson's Disease.帕金森病中神经炎症的潜在生物标志物与治疗
Actas Esp Psiquiatr. 2025 Jan;53(1):181-188. doi: 10.62641/aep.v53i1.1779.
10
Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.唾液和皮肤微生物群能否成为衰老相关疾病的生物探测器?当前见解与未来展望。
Front Aging. 2024 Oct 17;5:1462569. doi: 10.3389/fragi.2024.1462569. eCollection 2024.
Neurotox Res. 2020 Mar;37(3):491-507. doi: 10.1007/s12640-019-00147-2. Epub 2019 Dec 10.
4
α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.帕金森病患者下颌下腺α-突触核蛋白实时液滴震动诱导转化。
Mov Disord. 2020 Feb;35(2):268-278. doi: 10.1002/mds.27907. Epub 2019 Nov 23.
5
Antibiotic exposure and risk of Parkinson's disease in Finland: A nationwide case-control study.抗生素暴露与芬兰帕金森病风险的关系:一项全国性病例对照研究。
Mov Disord. 2020 Mar;35(3):431-442. doi: 10.1002/mds.27924. Epub 2019 Nov 18.
6
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.帕金森病患者的肠道微生物群改变和炎症细胞因子反应。
J Neuroinflammation. 2019 Jun 27;16(1):129. doi: 10.1186/s12974-019-1528-y.
7
The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.早期帕金森病的口腔微生物组及其与运动和非运动功能的功能测量的关系。
PLoS One. 2019 Jun 27;14(6):e0218252. doi: 10.1371/journal.pone.0218252. eCollection 2019.
8
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.帕金森病中的肠道微生物群:时间稳定性及其与疾病进展的关系。
EBioMedicine. 2019 Jun;44:691-707. doi: 10.1016/j.ebiom.2019.05.064. Epub 2019 Jun 18.
9
Systemic inflammatory burden and local inflammation in periodontitis: What is the link between inflammatory biomarkers in serum and gingival crevicular fluid?牙周炎中的全身炎症负担与局部炎症:血清和龈沟液中的炎症生物标志物之间有何联系?
Clin Exp Dent Res. 2019 Jan 24;5(2):128-135. doi: 10.1002/cre2.162. eCollection 2019 Apr.
10
Can oral bacteria affect the microbiome of the gut?口腔细菌会影响肠道微生物群吗?
J Oral Microbiol. 2019 Mar 18;11(1):1586422. doi: 10.1080/20002297.2019.1586422. eCollection 2019.